Cleo Diagnostics Ltd (COV) — Financial Flexibility Index
Cleo Diagnostics Ltd (COV) has a Financial Flexibility Index of -1.47x as of December 2025. Free cash flow of AU$-1.67 Million (operating CF AU$-1.67 Million minus capex AU$1.96K) represents -1% of total liabilities (AU$1.14 Million). Check Cleo Diagnostics Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Cleo Diagnostics Ltd Financial Flexibility Index (2023–2025)
Historical Financial Flexibility Index trend for Cleo Diagnostics Ltd across 3 annual periods. For the full cash flow conversion analysis, see how efficiently does Cleo Diagnostics Ltd generate cash.
Annual Financial Flexibility Index for Cleo Diagnostics Ltd (2023–2025)
Year-by-year free cash flow to debt coverage for Cleo Diagnostics Ltd. Explore COV cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (AUD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.62x | AU$-2.89 Million | AU$-2.90 Million | AU$1.10 Million | ▲ +37.1% |
| 2024 | -4.17x | AU$-2.03 Million | AU$-2.03 Million | AU$486.22K | ▼ -2346.6% |
| 2023 | -0.17x | AU$-344.23K | AU$-684.47K | AU$2.02 Million | — |